Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]PMPBB3 and [18F]THK5351 PET in Post-stroke Cognitive Impairment
NCT04318626Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florzolotau, 18F-THK5351 in stroke, cognitive impairment, sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
florzolotau18F-THK5351
03
Conditions
strokecognitive impairment
Beyond the preview
Go deeper on NCT04318626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04318626.